Russian strategy in Ukraine under pressure. Longer term impact of military action on economy

Emerging markets will dominate global growth - where 85% of humanity lives. Economy keynote speaker

Trust is the most important thing. Future of logistics and supply chain management - keynote speaker

Future of Sales and Marketing beyond COVID - hybrid event in Vilnius: physical audience of 800 + 300 virtual. Digital marketing, location marketing. How to create MAGIC in new marketing campaigns. Future of Marketing Keynote Speaker

Chances of 2 people in 70 having same birthday? Managing Risk in Banking and Financial Services. Why the greatest risks are combinations of very unlikely events, which happen far more often than you expect. Keynote speaker on risk management

Compliance is Dead. How to build trust. Reputation of banks and financial services. Compliance Risks. Why 100% compliance with regulations, ESG requirements etc is often not enough to prevent reputational damage

Life's too short to do things you don't believe in! Why passionate belief in the true value of what you are selling or doing is the number one key to success. Secret of all leadership and marketing - keynote for 1100 people in Vilnius October 2021

Why you can't innovate on Zoom or Teams meetings - Innovation is almost impossible unless breathing same air, in same room

Why the key to rapid innovation is team diversity - survey global CEOs. Innovation keynote speaker

Future Manufacturing 5.0. Lessons from personal life for all manufacturers. Manufacturing Keynote

Future of Manufacturing: diagnostics; predictive analytics, little data and cybersecurity. Keynote

Manufacturing 5 0: The truth about robots, robotics and automation. Future of Manufacturing Keynote

Human Cloning approved by HFEA - Cloning & Politics - Archive 1998

Futurist Keynote Speaker: Posts, Slides, Videos - What is Human Cloning? How to Clone. But Ethical?

"Made in Britain, Born elsewhere"

The HFEA (Human Fertilisation and Embryology Authority) and the HGAC (Human Genetics Advisory Commission) have recommended approval of human cloning for therapeutic purposes, but not to make baby clones.  That is the conclusion of their controversial report for the UK government, published on 8 December 1998 - supported by more recent announcements. 

Sir Colin Campbell, Chairman of the HGAC said then "New treatments might be developed for diseased or damaged tissue.  This would entail growing cells or tissues in culture and not involve human reproductive cloning.  It would not be right at this stage to rule out using such techniques, which could be of benefit to seriously ill people".  But the technology is identical - make a cloned embryo and implant it or cannibalise it for embryonic stem cells.

So it could have been full speed ahead for British scientists who can start human cloning with official backing - so long as the clones they make are destroyed to make human tissue factories, and not implanted into the womb.

However the government threw out the recommendations, ended the original advisory panels and set up a completely new process, scared perhaps of public reaction.  The new committee came to the same conclusions by August 2000.  The next step would be a Parliamentary debate in Autumn 2000.

If Parliament approves, it will be a huge gift for people like Dr Richard Seed, who can now hope to sit back and relax while big business and government funds research to perfect the basic cloning technique.  Once that's done, the baby cloners will step in, take the technology and use it.

Therefore I predict that if "therapeutic" cloning is approved, as a direct result, human clones could be made in Britain or using British technology, but will be born elsewhere.

The various committees have ridden over the wishes of the general public who have shown themselves to be very uneasy not only about the birth of human clones but also the use of cloning to make tissues for spare tissue factories.  I took part recently in a one hour TV debate on both reproductive and therapeutic cloning.  At the end, the studio was hit with 5,500 calls in three minutes from voters. 88% voted against both reproductive and therapeutic options.  Other surveys have found similar unease.  It's not that people are using language such as "morally wrong" but they just feel uncomfortable, perhaps one step too far.

1000 word feature on the 1998 original HFEA decision

Big business interests are at stake.  The press conference by HFEA was held at the Department of Trade and Industry.  The timing was brought forward after pressure from biotech companies who wanted a quick answer about the go-ahead.  When Dolly the sheep was cloned the shares of PPL Therapeutics rose by $60 million.  Dr Richard Seed has already raised $15 million to clone human babies.

What HFEA and other committees could and should have said:

1.    Total ban on birth of human clones and associated techniques - with urgent action to get international agreement on this through a Biotech summit.

2.    Moratorium on all human cloning research pending further debate, even where the aim is destroying the pre-implantation embryo in order to cultivate tissues for medical purposes.

The very fact that there has been SO much intense media debate (see below) in the hours before and after the announcement shows that the debate is ongoing.  The British people have NOT made up their minds.  The consultation process is NOT complete.   Indeed it has hardly begun.   The HFEA / HGAC based their entire conclusions on a mere 200 submissions - hardly a national consensus. We cannot go ahead with confidence.  Now is a time for further discussion, involving far more lay people.  The HFEA is dominated by those in the industry or those associated with it, and the HGAC is the same.  The British government must not allow itself to be stampeded into premature approval.


Related news items:
Older news items:

Thanks for promoting with Facebook LIKE or Tweet. Really interested to read your views. Post below.

Join the Debate! What are your own views?



Search for your future

Our cookie policy

We use cookies for statistical purposes. To comply with the e-Privacy Directive we need to ask your consent to place these cookies on your computer.

Your use of this site indicates acceptance of these terms. I accept